{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:54:47Z","timestamp":1780109687491,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T00:00:00Z","timestamp":1348963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s10549-012-2271-6","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T03:44:40Z","timestamp":1349063080000},"page":"407-417","source":"Crossref","is-referenced-by-count":63,"title":["Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer"],"prefix":"10.1007","volume":"136","author":[{"given":"Julia Y. S.","family":"Tsang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Bi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu-Ki","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C. W.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M. C.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,30]]},"reference":[{"issue":"10","key":"2271_CR1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755\u2013768. doi: 10.1038\/nrc2499","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2271_CR2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1582-4934.2007.00211.x","volume":"12","author":"AK Croker","year":"2008","unstructured":"Croker AK, Allan AL (2008) Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 12(2):374\u2013390. doi: 10.1111\/j.1582-4934.2007.00211.x","journal-title":"J Cell Mol Med"},{"issue":"7","key":"2271_CR3","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983\u20133988. doi: 10.1073\/pnas.05302911000530291100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2271_CR4","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr1610","volume":"8","author":"C Sheridan","year":"2006","unstructured":"Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H (2006) CD44+\/CD24\u2212 breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8(5):R59. doi: 10.1186\/bcr1610","journal-title":"Breast Cancer Res"},{"issue":"5","key":"2271_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5):555\u2013567. doi: 10.1016\/j.stem.2007.08.014","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2271_CR6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1349-7006.2009.01151.x","volume":"100","author":"K Morimoto","year":"2009","unstructured":"Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, Tamaki Y, Terada N, Noguchi S (2009) Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci 100(6):1062\u20131068. doi: 10.1111\/j.1349-7006.2009.01151.x","journal-title":"Cancer Sci"},{"issue":"5","key":"2271_CR7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2353\/ajpath.2010.090712","volume":"176","author":"V Neumeister","year":"2010","unstructured":"Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL (2010) In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol 176(5):2131\u20132138. doi: 10.2353\/ajpath.2010.090712","journal-title":"Am J Pathol"},{"issue":"10","key":"2271_CR8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1593\/neo.09670","volume":"11","author":"M Buess","year":"2009","unstructured":"Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C (2009) Tumor-endothelial interaction links the CD44(+)\/CD24(\u2212) phenotype with poor prognosis in early-stage breast cancer. Neoplasia 11(10):987\u20131002","journal-title":"Neoplasia"},{"issue":"11","key":"2271_CR9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.2011.090456","volume":"64","author":"S Ricardo","year":"2011","unstructured":"Ricardo S, Vieira AF, Gerhard R, Leitao D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J (2011) Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 64(11):937\u2013946. doi: 10.1136\/jcp.2011.090456","journal-title":"J Clin Pathol"},{"issue":"3","key":"2271_CR10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/1078-0432.1154.11.3","volume":"11","author":"BK Abraham","year":"2005","unstructured":"Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H (2005) Prevalence of CD44+\/CD24\u2212\/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11(3):1154\u20131159","journal-title":"Clin Cancer Res"},{"key":"2271_CR11","author":"MA Ahmed","year":"2011","unstructured":"Ahmed MA, Aleskandarany MA, Rakha EA, Moustafa RZ, Benhasouna A, Nolan C, Green AR, Ilyas M, Ellis IO (2011) A CD44(\u2212)\/CD24 (+) phenotype is a poor prognostic marker in early invasive breast cancer. Breast Cancer Res Treat. doi: 10.1007\/s10549-011-1865-8","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2271_CR12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.humpath.2007.12.003","volume":"39","author":"E Mylona","year":"2008","unstructured":"Mylona E, Giannopoulou I, Fasomytakis E, Nomikos A, Magkou C, Bakarakos P, Nakopoulou L (2008) The clinicopathologic and prognostic significance of CD44+\/CD24(\u2212\/low) and CD44\u2212\/CD24+ tumor cells in invasive breast carcinomas. Hum Pathol 39(7):1096\u20131102. doi: 10.1016\/j.humpath.2007.12.003","journal-title":"Hum Pathol"},{"issue":"12","key":"2271_CR13","doi-asserted-by":"crossref","first-page":"e8377","DOI":"10.1371\/journal.pone.0008377","volume":"4","author":"WW Hwang-Verslues","year":"2009","unstructured":"Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, Lee EY, Chang KJ, Lee WH (2009) Multiple lineages of human breast cancer stem\/progenitor cells identified by profiling with stem cell markers. PLoS ONE 4(12):e8377. doi: 10.1371\/journal.pone.0008377","journal-title":"PLoS ONE"},{"issue":"5","key":"2271_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403\u2013410","journal-title":"Histopathology"},{"key":"2271_CR15","volume-title":"World Health Organisation classification of tumors of the breast","year":"2012","unstructured":"Lakhani SR, Ellis IO, Schnitee SJ, Tan PH, van de Vijver MJ (eds) (2012) World Health Organisation classification of tumors of the breast, 4th edn. IARC Press, Lyon","edition":"4"},{"issue":"16","key":"2271_CR16","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784\u20132795. doi: 10.1200\/JCO.2009.25.6529","journal-title":"J Clin Oncol"},{"issue":"1","key":"2271_CR17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118\u2013145. doi: 10.1200\/JCO.2006.09.2775","journal-title":"J Clin Oncol"},{"issue":"6","key":"2271_CR18","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/bcr3061","volume":"13","author":"HR Ali","year":"2011","unstructured":"Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C (2011) Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance. Breast Cancer Res 13(6):R118. doi: 10.1186\/bcr3061","journal-title":"Breast Cancer Res"},{"issue":"8","key":"2271_CR19","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736\u20131747. doi: 10.1093\/annonc\/mdr304","journal-title":"Ann Oncol"},{"issue":"16","key":"2271_CR20","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10(16):5367\u20135374. doi: 10.1158\/1078-0432.CCR-04-022010\/16\/5367","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2271_CR21","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/bcr2108","volume":"10","author":"G Honeth","year":"2008","unstructured":"Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K, Grabau D, Ferno M, Borg A, Hegardt C (2008) The CD44+\/CD24\u2212 phenotype is enriched in basal-like breast tumors. Breast Cancer Res 10(3):R53. doi: 10.1186\/bcr2108","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2271_CR22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/1078-0432.CCR-09-1532","volume":"16","author":"SY Park","year":"2010","unstructured":"Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K (2010) Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 16(3):876\u2013887. doi: 10.1158\/1078-0432.CCR-09-1532","journal-title":"Clin Cancer Res"},{"issue":"47","key":"2271_CR23","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/onc.2008.207","volume":"27","author":"H Korkaya","year":"2008","unstructured":"Korkaya H, Paulson A, Iovino F, Wicha MS (2008) HER2 regulates the mammary stem\/progenitor cell population driving tumorigenesis and invasion. Oncogene 27(47):6120\u20136130. doi: 10.1038\/onc.2008.207","journal-title":"Oncogene"},{"issue":"8","key":"2271_CR24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2009.125377","volume":"55","author":"MJ Higgins","year":"2009","unstructured":"Higgins MJ, Stearns V (2009) Understanding resistance to tamoxifen in hormone receptor-positive breast cancer. Clin Chem 55(8):1453\u20131455. doi: 10.1373\/clinchem.2009.125377","journal-title":"Clin Chem"},{"issue":"30","key":"2271_CR25","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1200\/JCO.2007.12.2747","volume":"25","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO (2007) Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol 25(30):4772\u20134778. doi: 10.1200\/JCO.2007.12.2747","journal-title":"J Clin Oncol"},{"issue":"1","key":"2271_CR26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2005-864031","volume":"23","author":"R Fernandez-Valdivia","year":"2005","unstructured":"Fernandez-Valdivia R, Mukherjee A, Mulac-Jericevic B, Conneely OM, DeMayo FJ, Amato P, Lydon JP (2005) Revealing progesterone\u2019s role in uterine and mammary gland biology: insights from the mouse. Semin Reprod Med 23(1):22\u201337. doi: 10.1055\/s-2005-864031","journal-title":"Semin Reprod Med"},{"key":"2271_CR27","doi-asserted-by":"crossref","unstructured":"Hilton HN, Graham JD, Kantimm S, Santucci N, Cloosterman D, Huschtscha LI, Mote PA, Clarke CL (2012) Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. Mol Cell Endocrinol. doi: 10.1016\/j.mce.2012.04.010","DOI":"10.1016\/j.mce.2012.04.010"},{"issue":"15","key":"2271_CR28","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.0706216105","volume":"105","author":"KB Horwitz","year":"2008","unstructured":"Horwitz KB, Dye WW, Harrell JC, Kabos P, Sartorius CA (2008) Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc Natl Acad Sci USA 105(15):5774\u20135779. doi: 10.1073\/pnas.0706216105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7299","key":"2271_CR29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","volume":"465","author":"PA Joshi","year":"2010","unstructured":"Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R (2010) Progesterone induces adult mammary stem cell expansion. Nature 465(7299):803\u2013807. doi: 10.1038\/nature09091","journal-title":"Nature"},{"issue":"1","key":"2271_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10549-010-1169-4","volume":"129","author":"BM Simoes","year":"2011","unstructured":"Simoes BM, Piva M, Iriondo O, Comaills V, Lopez-Ruiz JA, Zabalza I, Mieza JA, Acinas O, Vivanco MD (2011) Effects of estrogen on the proportion of stem cells in the breast. Breast Cancer Res Treat 129(1):23\u201335. doi: 10.1007\/s10549-010-1169-4","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"2271_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.breast.2009.09.002","volume":"18","author":"R Stuart-Harris","year":"2009","unstructured":"Stuart-Harris R, Shadbolt B, Palmqvist C, Chaudri Ross HA (2009) The prognostic significance of single hormone receptor positive metastatic breast cancer: an analysis of three randomised phase III trials of aromatase inhibitors. Breast 18(6):351\u2013355. doi: 10.1016\/j.breast.2009.09.002","journal-title":"Breast"},{"issue":"1","key":"2271_CR32","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr1639","volume":"9","author":"LK Dunnwald","year":"2007","unstructured":"Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6. doi: 10.1186\/bcr1639","journal-title":"Breast Cancer Res"},{"issue":"5","key":"2271_CR33","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MC Cheang","year":"2008","unstructured":"Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5):1368\u20131376. doi: 10.1158\/1078-0432.CCR-07-1658","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2271_CR34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/path.1559","volume":"203","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203(2):661\u2013671. doi: 10.1002\/path.1559","journal-title":"J Pathol"},{"issue":"1","key":"2271_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-010-1078-6","volume":"128","author":"P Kabos","year":"2011","unstructured":"Kabos P, Haughian JM, Wang X, Dye WW, Finlayson C, Elias A, Horwitz KB, Sartorius CA (2011) Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. Breast Cancer Res Treat 128(1):45\u201355. doi: 10.1007\/s10549-010-1078-6","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2271-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2271-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:50:28Z","timestamp":1687740628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2271-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,30]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2271"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2271-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,30]]}}}